Financial giants have made a conspicuous bearish move on Abbott Laboratories. Our analysis of options history for Abbott Laboratories ABT revealed 20 unusual trades.
Delving into the details, we found 40% of traders were bullish, while 45% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $250,731, and 18 were calls, valued at $6,957,978.
Projected Price Targets
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $135.0 for Abbott Laboratories over the last 3 months.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Abbott Laboratories's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Abbott Laboratories's significant trades, within a strike price range of $75.0 to $135.0, over the past month.
Abbott Laboratories Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABT | CALL | TRADE | BEARISH | 01/15/27 | $27.5 | $23.0 | $24.1 | $115.00 | $6.0M | 3.6K | 2.5K |
| ABT | PUT | SWEEP | BEARISH | 02/14/25 | $2.3 | $2.0 | $2.0 | $129.00 | $190.8K | 0 | 1.0K |
| ABT | CALL | SWEEP | BEARISH | 01/15/27 | $32.6 | $31.15 | $31.15 | $105.00 | $133.9K | 278 | 43 |
| ABT | CALL | SWEEP | BULLISH | 02/21/25 | $2.05 | $1.89 | $2.05 | $130.00 | $101.9K | 2.9K | 2.4K |
| ABT | CALL | SWEEP | NEUTRAL | 09/19/25 | $19.55 | $19.15 | $19.27 | $115.00 | $75.2K | 376 | 50 |
About Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Following our analysis of the options activities associated with Abbott Laboratories, we pivot to a closer look at the company's own performance.
Present Market Standing of Abbott Laboratories
- Trading volume stands at 5,462,045, with ABT's price up by 3.42%, positioned at $129.31.
- RSI indicators show the stock to be may be overbought.
- Earnings announcement expected in 79 days.
What The Experts Say On Abbott Laboratories
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $142.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Abbott Laboratories with a target price of $158. * Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Abbott Laboratories with a target price of $148. * An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $135. * An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $135. * An analyst from Stifel persists with their Buy rating on Abbott Laboratories, maintaining a target price of $135.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Abbott Laboratories, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
